https://www.business-standard.com/companies/news/eris-to-buy-derma-nephro-units-of-biocon-biologics-for-rs-366-cr-123110800819_1.html
Biocon Biologics: The business includes over 20 mother brands with revenue of Rs 90 crore in FY23 and the current run-rate is around Rs 100 crore
Create an account or login to join the discussion